Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07032389 · ClinicalTrials.gov registry record · Phase 2
A Polypill for Acute Coronary Syndrome
A Phase 2 study of Acute Coronary Syndrome, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 1,000
- Enrollment target
- 1
- Study location
NCT07032389: Recruiting Phase 2 study of Acute Coronary Syndrome, sponsored by University of Texas Southwestern Medical Center.
NCT07032389 is a Phase 2 study of Acute Coronary Syndrome that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 1,000 participants, below the 2,697-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07032389, a Phase 2 study of Acute Coronary Syndrome, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The current study aims to investigate whether combining the standard medications prescribed after acute coronary syndrome (ACS)-aspirin, P2Y12 inhibitors, and statins-into a single polypill can improve outcomes following an ACS event. Although these therapies are effective, gaps in adherence and uptake significantly contribute to risk or adverse events in the post-ACS period. This study is designed as a pragmatic, multi-center, randomized trial to assess the feasibility and effectiveness of a polypill-based strategy for treatment of ACS.
Primary Outcome
The win ratio will include all-cause death, in-stent thrombosis, ischemic events (MI, hospitalization for unstable angina, unplanned revascularization), and bleeding events (hospitalization or ED visit for bleeding, red blood cell transfusion, or a bleeding event that leads to cessation of DAPT)
Conditions Studied
Interventions
- COMBINATION_PRODUCT Polypill
Study Locations (1)
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2025-12-05 |
| Est. Completion | 2029-08-01 |
| Phase | Phase 2 |
What NCT07032389 shows while recruiting
NCT07032389 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 2,697-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target (63% lower).
The record links to 1 condition, with Acute Coronary Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Polypill is the first listed.
NCT07032389 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07032389 about?
NCT07032389 is a clinical study titled "A Polypill for Acute Coronary Syndrome". The current study aims to investigate whether combining the standard medications prescribed after acute coronary syndrome (ACS)-aspirin, P2Y12 inhibitors, and statins-into a single polypill can improve outcomes following an ACS event. Although these therapies are effective, gaps in adherence and upt...
What is the current status of trial NCT07032389?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 1,000 participants. The study started on 2025-12-05. Estimated completion is 2029-08-01.
What conditions does trial NCT07032389 study?
This clinical trial studies the following conditions: Acute Coronary Syndrome.
What interventions are being tested in trial NCT07032389?
The interventions under investigation include: Polypill (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT07032389?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07032389 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Coronary Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07032389's enrollment target sits among peer trials
1,000 15th of 40 higher than 26 of 40 other Acute Coronary Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Coronary Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Online Tai Chi Plus Fitbit After ACS
ACTIVE NOT RECRUITING · Phase 2
-
Safety and Efficacy Iodofiltic Acid I 123 in the Treatment of Acute Coronary Syndrome
COMPLETED · Phase 2
-
Safety and Efficacy of TAK-442 in Subjects With Acute Coronary Syndromes
COMPLETED · Phase 2
-
A Study to Evaluate the Safety of 12 Weeks of Dosing With GW856553 and Its Effects on Inflammatory Markers, Infarct Size, and Cardiac Function in Subjects With Myocardial Infarction Without ST-segment Elevation
COMPLETED · Phase 2
-
Positive Emotions Following Acute Cardiac Events
RECRUITING · NA
-
Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI